Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing
Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)
Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC